The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Involvement of BCRP (ABCG2) in the Biliary Excretion of Pitavastatin
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A pharmacokinetic analysis program (multi) for microcomputer.
YAMAOKA, K., TANIGAWARA, Y., NAKAGAWA, T., & UNO, T. (1981) · Journal of Pharmacobio-Dynamics · doi:10.1248/bpb1978.4.879 · Cited by 2,450
Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C. L. M., Schinkel, A. H., van de Vijver, M. J., Scheper, R. J., & Schellens, J. H. M. (2001) · PubMed · Cited by 1,130
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
Austin Doyle, L., & Ross, D. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206938 · Cited by 1,051
Allikmets, R., Schriml, L. M., Hutchinson, A. A., Romano-Spica, V., & Dean, M. C. (1998) · PubMed · Cited by 918
Jonker, J. W., Buitelaar, M., Wagenaar, E., van der Valk, M. A., Scheffer, G. L., Scheper, R. J., Plösch, T., Kuipers, F., Elferink, R. P. J. O., Rosing, H., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202607599 · Cited by 822
Role of Breast Cancer Resistance Protein in the Bioavailability and Fetal Penetration of Topotecan
Jonker, J. W. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.20.1651 · Cited by 638
Müller, M., Meijer, C., Zaman, G. J., Borst, P., Scheper, R. J., Mulder, N. H., de Vries, E. G., & Jansen, P. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.13033 · Cited by 617
OATP and P-Glycoprotein Transporters Mediate the Cellular Uptake and Excretion of Fexofenadine
Cvetkovic, M., Leake, B., Fromm, M. F., Wilkinson, G. R., & Kim, R. B. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15235-x · Cited by 597
Nishizato, Y. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00060-2 · Cited by 511
Kruijtzer, C. M. F., Beijnen, J. H., Rosing, H., ten Bokkel Huinink, W. W., Schot, M., Jewell, R. C., Paul, E. M., & Schellens, J. H. M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.116 · Cited by 464
Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the Hepatic Uptake of Pitavastatin in Humans
Hirano, M., Maeda, K., Shitara, Y., & Sugiyama, Y. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068056 · Cited by 443
Self-citationImai, Y., Nakane, M., Kage, K., Tsukahara, S., Ishikawa, E., Tsuruo, T., Miki, Y., & Sugimoto, Y. (2002) · PubMed · Cited by 442
Comparison of statins in hypertriglyceridemia
Stein, E. A., Lane, M., & Laskarzewski, P. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00041-1 · Cited by 386
Hirohashi, T., Suzuki, H., & Sugiyama, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.15181 · Cited by 347
Self-citationABCG2 Transports Sulfated Conjugates of Steroids and Xenobiotics
Suzuki, M., Suzuki, H., Sugimoto, Y., & Sugiyama, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212399200 · Cited by 341
Self-citationZamber, C. P., Lamba, J. K., Yasuda, K., Farnum, J., Thummel, K., Schuetz, J. D., & Schuetz, E. G. (2003) · Pharmacogenetics · doi:10.1097/00008571-200301000-00004 · Cited by 272
van Herwaarden, A. E., Jonker, J. W., Wagenaar, E., Brinkhuis, R. F., Schellens, J. H. M., Beijnen, J. H., & Schinkel, A. H. (2003) · PubMed · Cited by 269
FUNCTIONAL ASSESSMENT OF ABCG2 (BCRP) GENE POLYMORPHISMS TO PROTEIN EXPRESSION IN HUMAN PLACENTA
Kobayashi, D., Ieiri, I., Hirota, T., Takane, H., Maegawa, S., Kigawa, J., Suzuki, H., Nanba, E., Oshimura, M., Terakawa, N., et al. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001628 · Cited by 268
Self-citationThe Complexities of Hepatic Drug Transport: Current Knowledge and Emerging Concepts
Chandra, P., & Brouwer, K. L. R. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000026420.79421.8f · Cited by 266
Functional Analysis of SNPs Variants of BCRP/ABCG2
Kondo, C., Suzuki, H., Itoda, M., Ozawa, S., Sawada, J.-I., Kobayashi, D., Ieiri, I., Mine, K., Ohtsubo, K., & Sugiyama, Y. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045245.21637.d4 · Cited by 264
Self-citationCharacterization of inducible nature of MRP3 in rat liver
Ogawa, K., Suzuki, H., Hirohashi, T., Ishikawa, T., Meier, P. J., Hirose, K., Akizawa, T., Yoshioka, M., & Sugiyama, Y. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.3.g438 · Cited by 253
Self-citationDiflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype*1
SPARREBOOM, A. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.03.003 · Cited by 241
Sasaki, M., Suzuki, H., Ito, K., Abe, T., & Sugiyama, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109081200 · Cited by 228
Self-citationMerino, G., Jonker, J. W., Wagenaar, E., van Herwaarden, A. E., & Schinkel, A. H. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010439 · Cited by 228
Matsushima, S., Maeda, K., Kondo, C., Hirano, M., Sasaki, M., Suzuki, H., & Sugiyama, Y. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085589 · Cited by 190
Self-citationBile Salt Export Pump (BSEP/ABCB11) Can Transport a Nonbile Acid Substrate, Pravastatin
Hirano, M., Maeda, K., Hayashi, H., Kusuhara, H., & Sugiyama, Y. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084830 · Cited by 181
Self-citationMerino, G., van Herwaarden, A. E., Wagenaar, E., Jonker, J. W., & Schinkel, A. H. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011080 · Cited by 178
Preclinical pharmacokinetics of statins
Reinoso, R. F., Sanchez Navarro, A., Garcia, M. J., & Prous, J. (2002) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2002.24.9.802312 · Cited by 154
Iwai, M., Suzuki, H., Ieiri, I., Otsubo, K., & Sugiyama, Y. (2004) · Pharmacogenetics · doi:10.1097/00008571-200411000-00006 · Cited by 147
Self-citationYamazaki, M., Akiyama, S., Ni'inuma, K., Nishigaki, R., & Sugiyama, Y. (1997) · PubMed · doi:10.7270/q2cr5vmx · Cited by 140
Self-citationPitavastatin: Efficacy and Safety Profiles of A Novel Synthetic HMG‐CoA Reductase Inhibitor
Kajinami, K., Takekoshi, N., & Saito, Y. (2003) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2003.tb00116.x · Cited by 136 · cited 2×
“Therefore, the pharmacokinetics of several important compounds are regulated mainly by BCRP. Pitavastatin is a highly potent inhibitor of 3-hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme in cholesterol biosynthesis (Kajinami et al., 2003).”
BackgroundClinical pharmacokinetics of statins
Garcia, M. J., Reinoso, R. F., Sanchez Navarro, A., & Prous, J. R. (2003) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2003.25.6.769652 · Cited by 121
Mizuno, N., Suzuki, M., Kusuhara, H., Suzuki, H., Takeuchi, K., Niwa, T., Jonker, J. W., & Sugiyama, Y. (2004) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)02969-6 · Cited by 99
Self-citationSasaki, M., Suzuki, H., Aoki, J., Ito, K., Meier, P. J., & Sugiyama, Y. (2004) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)05627-x · Cited by 96
Self-citationAdachi, Y., Suzuki, H., Schinkel, A. H., & Sugiyama, Y. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.007393 · Cited by 90
Self-citationKIMATA, H., Fujino, H., Koide, T., Yamada, Y. M. A., Tsunenari, Y., & Yanagawa, Y. (1998) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.13.484 · Cited by 51
Fujino, H., Yamada, I., Shimada, S., & Kojima, J. (2002) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.17.449 · Cited by 27
Interaction between Several Medicines and Statins
Fujino, H., Saito, T., Tsunenari, Y., & Kojima, J. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1297087 · Cited by 20
Effect of Biliary Excretion on the Pharmacokinetics of Pitavastatin (NK-104) in Dogs.
Kojima, J., OHSHIMA, T., Yoneda, M., & Sawada, H. (2001) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.16.497 · Cited by 14
Cited by
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Self-citationABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Choi, Y., & Yu, A.-M. (2014) · Current Pharmaceutical Design · doi:10.2174/138161282005140214165212 · Cited by 629
Ho, R. H., Tirona, R. G., Leake, B. F., Glaeser, H., Lee, W., Lemke, C. J., Wang, Y., & Kim, R. B. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.034 · Cited by 611
Shitara, Y., & Sugiyama, Y. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.03.003 · Cited by 576
Self-citationTransporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects
König, J., Müller, F., & Fromm, M. F. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007518 · Cited by 575
Metadata
- Authors
- Hirano, M., Maeda, K., Matsushima, S., Nozaki, Y., Kusuhara, H., & Sugiyama, Y.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 68
- Issue
- 3
- Pages
- 800-807
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2167145816
- Cited by
- 256
- References
- 39
- FWCI
- 8.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.